Search Results 1811-1820 of 17350 for monoclonal antibody

1. Medical Research & Education - Mayo Clinic News Network

   Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science Saturday: The importance of antibody testing in addressing COVID-19 featured ...

2. Haemophilus b conjugate and hepatitis b vaccine (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Infections with Haemophilus influenza type b (Hib) ...

3. Meningococcal polysaccharide vaccine, diphtheria conjugate (intramuscular route) - Side effects & uses - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the bacteria. The following information applies only to the ...

4. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   quantitative IgM monoclonal protein > 1,000 mg/dL. ANC ≥ 1000/uL; Hgb ≥ 9 g/dl; PLT ≥ 75,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if ...

5. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial - Mayo Clinic

   ... antibody and/or small molecule treatment is allowed, except for PARP inhibitors). Life expectancy >6 months; ECOG performance status 0 or 1. (Form is ...

6. Dried Blood Spot COVID-19 Vaccination Response (Enrolling by Invitation Only) - Mayo Clinic

   Subjects who test SARS-CoV-2 antibody positive on the pre-vaccination sample indicating prior infection. Participating Mayo Clinic locations. Study statuses ...

7. Point of Care Lateral Flow Assay for Coccidioidomycosis - Mayo Clinic

   Immunosuppression where antibody production is anticipated to be compromised, either by underlying or acquired comorbid illness (such as but not limited to ...

8. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

   Prior treatment with Cluster of differentiation 33 (CD33) antibody Further exclusion criteria apply. Participating Mayo Clinic locations. Study statuses ...

9. Mayo Clinic Minute: What is chimeric antigen receptor-T cell therapy? Chimeric antigen receptor-T cell therapy, also known as CA

   and antibody-based treatments. But for those patients who do not respond to two or more lines of such treatments, CAR-T cell therapy may be an option ...

10. Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab - Mayo Clinic

    ... antibodies). New onset or signs and symptoms of any form of ... Prior exposure to any anti-IgE antibody therapy other than omalizumab and ligelizumab.